Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis (MuSicalE)
A Multicentre Non-interventional Study to Assess the Real-world Effectiveness of Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis - The MuSicalE STUDY
Sponsor: Hoffmann-La Roche
A observational or N/A phase clinical study on Multiple Sclerosis, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 53 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
53 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Nov 2025 — Dec 2025 [monthly]
Active Not Recruiting
-
Oct 2025 — Nov 2025 [monthly]
Active Not Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting
▶ Show 48 earlier versions
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Apr 2025 — Jul 2025 [monthly]
Active Not Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Active Not Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting
-
Oct 2024 — Jan 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — Jun 2024 [monthly]
Active Not Recruiting
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting
-
Dec 2023 — Feb 2024 [monthly]
Active Not Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Active Not Recruiting
-
Jul 2023 — Oct 2023 [monthly]
Active Not Recruiting
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting
-
Sep 2022 — May 2023 [monthly]
Active Not Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Active Not Recruiting
-
Mar 2022 — Jun 2022 [monthly]
Active Not Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Feb 2022 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Apr 2021 — May 2021 [monthly]
Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting
-
Apr 2020 — Jun 2020 [monthly]
Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
-
Oct 2019 — Dec 2019 [monthly]
Recruiting
-
Aug 2019 — Oct 2019 [monthly]
Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Recruiting
-
Apr 2019 — Jun 2019 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Dec 2018 — Feb 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Amstetten, Austria , Ankara, Turkey (Türkiye) , Asunción, Paraguay , Barcelona, Spain , Bari, Italy , Belfast, United Kingdom , Bialystok, Poland , Bogota, DC, Colombia , Bogotá, Colombia and 120 more locations